ATE287714T1 - Pharmazeutische emulsionen für retroviral- protease hemmende verbindungen - Google Patents
Pharmazeutische emulsionen für retroviral- protease hemmende verbindungenInfo
- Publication number
- ATE287714T1 ATE287714T1 AT00917940T AT00917940T ATE287714T1 AT E287714 T1 ATE287714 T1 AT E287714T1 AT 00917940 T AT00917940 T AT 00917940T AT 00917940 T AT00917940 T AT 00917940T AT E287714 T1 ATE287714 T1 AT E287714T1
- Authority
- AT
- Austria
- Prior art keywords
- inhibiting compounds
- retroviral protease
- protease inhibiting
- pharmaceutical emulsions
- emulsions
- Prior art date
Links
- 108091005804 Peptidases Proteins 0.000 title 1
- 239000004365 Protease Substances 0.000 title 1
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 title 1
- 150000001875 compounds Chemical class 0.000 title 1
- 230000002401 inhibitory effect Effects 0.000 title 1
- 239000008251 pharmaceutical emulsion Substances 0.000 title 1
- 230000001177 retroviral effect Effects 0.000 title 1
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 abstract 1
- VOLMSPGWNYJHQQ-UHFFFAOYSA-N Pyranone Natural products CC1=C(O)C(=O)C(O)CO1 VOLMSPGWNYJHQQ-UHFFFAOYSA-N 0.000 abstract 1
- 239000003995 emulsifying agent Substances 0.000 abstract 1
- 239000000839 emulsion Substances 0.000 abstract 1
- 238000009472 formulation Methods 0.000 abstract 1
- 239000000787 lecithin Substances 0.000 abstract 1
- 229940067606 lecithin Drugs 0.000 abstract 1
- 235000010445 lecithin Nutrition 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- -1 pyranone compound Chemical class 0.000 abstract 1
- 239000002904 solvent Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
- A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Virology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Communicable Diseases (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Molecular Biology (AREA)
- Tropical Medicine & Parasitology (AREA)
- AIDS & HIV (AREA)
- Biophysics (AREA)
- Dispersion Chemistry (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US12702699P | 1999-03-31 | 1999-03-31 | |
| PCT/US2000/006681 WO2000057885A1 (en) | 1999-03-31 | 2000-03-22 | Pharmaceutical emulsions for retroviral protease inhibitors |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE287714T1 true ATE287714T1 (de) | 2005-02-15 |
Family
ID=22427949
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT00917940T ATE287714T1 (de) | 1999-03-31 | 2000-03-22 | Pharmazeutische emulsionen für retroviral- protease hemmende verbindungen |
Country Status (8)
| Country | Link |
|---|---|
| EP (1) | EP1165091B1 (de) |
| JP (1) | JP4638053B2 (de) |
| AT (1) | ATE287714T1 (de) |
| AU (1) | AU3883700A (de) |
| DE (1) | DE60017720T2 (de) |
| ES (1) | ES2234582T3 (de) |
| PT (1) | PT1165091E (de) |
| WO (1) | WO2000057885A1 (de) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE0000774D0 (sv) | 2000-03-08 | 2000-03-08 | Astrazeneca Ab | New formulation |
| SE0102993D0 (sv) * | 2001-09-07 | 2001-09-07 | Astrazeneca Ab | New self emulsifying drug delivery system |
| EP2320740B1 (de) * | 2008-08-01 | 2014-03-26 | The Medicines Company | Pharmazeutische zusammensetzungen von clividipine und verfahren zur herstellung von konzentrationen daraus mit geringem verunreinigungsgrad |
| CN102627654B (zh) * | 2012-05-08 | 2013-11-27 | 山东大学 | 含异山梨醇结构单元的hiv-1蛋白酶抑制剂及其制备方法与应用 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1112927C (zh) * | 1997-07-29 | 2003-07-02 | 法玛西雅厄普约翰美国公司 | 自体乳化剂形式的酸性亲脂性化合物的药物组合物 |
| KR100509130B1 (ko) * | 1997-07-29 | 2005-08-18 | 파마시아 앤드 업존 캄파니 엘엘씨 | 친지성 화합물의 자가유화 제제 |
-
2000
- 2000-03-22 ES ES00917940T patent/ES2234582T3/es not_active Expired - Lifetime
- 2000-03-22 AT AT00917940T patent/ATE287714T1/de active
- 2000-03-22 DE DE60017720T patent/DE60017720T2/de not_active Expired - Lifetime
- 2000-03-22 JP JP2000607635A patent/JP4638053B2/ja not_active Expired - Fee Related
- 2000-03-22 AU AU38837/00A patent/AU3883700A/en not_active Abandoned
- 2000-03-22 WO PCT/US2000/006681 patent/WO2000057885A1/en not_active Ceased
- 2000-03-22 PT PT00917940T patent/PT1165091E/pt unknown
- 2000-03-22 EP EP00917940A patent/EP1165091B1/de not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| JP2002540158A (ja) | 2002-11-26 |
| EP1165091B1 (de) | 2005-01-26 |
| WO2000057885A1 (en) | 2000-10-05 |
| ES2234582T3 (es) | 2005-07-01 |
| DE60017720T2 (de) | 2006-01-12 |
| EP1165091A1 (de) | 2002-01-02 |
| PT1165091E (pt) | 2005-05-31 |
| DE60017720D1 (de) | 2005-03-03 |
| JP4638053B2 (ja) | 2011-02-23 |
| AU3883700A (en) | 2000-10-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO933482D0 (no) | N-sulfonyl-2-oksoindol-derivater som har affinitet for vasopressin- og/eller ocytocin-reseptorer | |
| DK0989851T3 (da) | Selvemulgerende formulering indeholdende sure lipofile forbindelser | |
| AR077414A2 (es) | Compuestos de piperazina como antagonistas de taquinina sus sales y solvatos composiciones farmaceuticas que lo contienen su uso y procesos para su preparacion | |
| BR0212386A (pt) | Composto, formulação farmacêutica, e, uso de um composto | |
| FI962735A0 (fi) | 2-hydroksi-5-fenylatsobensoehapon johdannaisten käyttö paksusuolen syövän kemialliseen ehkäisyyn ja kemoterapeuttisena aineena | |
| ATE505184T1 (de) | Medizinische aerosolformulierung | |
| BR0210078A (pt) | Composto, uso do mesmo, e, formulação farmacêutica | |
| ES2175624T3 (es) | Derivados de pirazolo(4,3-d)pirimidina y composiciones farmaceuticas que los contienen. | |
| BR9911013A (pt) | Derivados de pirazol como inibidores da p-38 map quinase | |
| ATE289590T1 (de) | Beta-sulfonyl-hydroxamsäuren als matrix- metalloproteinaseinhibitoren | |
| CY1109364T1 (el) | Ενας συνδυασμος που περιλαμβανει κομβρεταστατινη και αντικαρκινικους παραγοντες | |
| CY1110261T1 (el) | Παραγωγα της κουμαρινης που χρησιμοποιουνται σαν αντιπηκτικα | |
| NO20062019L (no) | P-glykoproteininhibitor, fremgangsmater for fremstilling av denne samt farmasoytiske preparater inneholdende den samme | |
| DE60236456D1 (de) | Liposomale abgabe von verbindungen auf vitamin-e-basis | |
| KR970704444A (ko) | 트리아진 유도체 및 의약(triazine derivative and medicine) | |
| DE60301339D1 (de) | Pyrazolopyrimidin- und pyrazolotriazinderivate und diese enthaltende pharmazeutische zubereitungen | |
| KR960006915A (ko) | 췌장염의 치료 조성물 | |
| AR029509A1 (es) | Una composicion farmaceutica en base a un compuesto de platino (iv) y el uso de dicho compuesto para preparar medicamentos antitumorales | |
| ATE287714T1 (de) | Pharmazeutische emulsionen für retroviral- protease hemmende verbindungen | |
| ATE373000T1 (de) | Pyrazolopyridin-derivate als antiherpesmittel | |
| AU2002248531A1 (en) | Pyrazolopyriadine derivatives | |
| EA200000068A3 (ru) | Новые цианоиндольные соединения, являющиеся ингибиторами повторного захвата серотонина, способ их получения и фармацевтические композиции, содержащие их | |
| DK0853476T3 (da) | Nimesulidholdigt farmaceutisk præparat til topisk anvendelse | |
| NO20000654L (no) | 1,3-dioksolo/4.5-H/2.3/Benzodiazepinderivater som AMPA/kainareseptorinhibitorer | |
| TR200001055T2 (tr) | Yeni metilenbifosfonik asit türevleri |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1165091 Country of ref document: EP |
|
| EEIH | Change in the person of patent owner |